Search Tag: Bayer
2023 02 Mar
The future of medical imaging and the role of AI: Bayer reinforces commitment to innovation in Radiology Focus on artificial intelligence (AI) and its potential to address key challenges in radiology today Education and training are key to enable an effective adoption of AI Building on a deep medical expertise, Bayer is driving innovation in...Read more
2023 22 Feb
Featured presentations include development compound gadoquatrane, a novel contrast agent for MRI Further research explores potential of AI and digital advances in medical imaging Bayer announced that new data from the company’s advanced radiology portfolio will be presented at the 2023 European Congress of Radiology (ECR), taking place from...Read more
2023 13 Feb
Closing follows announcement of acquisition on January 18, 2023 Acquisition bolsters Bayer’s position in digital medical imaging Blackford will utilize Bayer’s well established “arm’s length” operating model to preserve the company’s entrepreneurial culture Bayer announced that the company has completed the acquisition of the global strategic...Read more
2023 18 Jan
Acquisition is part of Bayer’s innovation strategy in radiology Blackford Analysis provides cutting-edge radiology AI (artificial intelligence) platform technology Following closing of the acquisition, Blackford Analysis to become part of Bayer’s well established “arm’s length” operating model to preserve the company’s entrepreneurial culture...Read more
2022 28 Jun
AI applications for medical imaging can improve prioritization, lesion detection,quantification and productivity Cloud-hosted platform provides access to AI applications* that integrate into standard medical imaging workflow Market introduction to start in US and several European countries Strategically complements Bayer’s comprehensive portfolio...Read more
2015 14 Jul
Approval based on data demonstrating the pharmacokinetic and safety profiles of Gadovist at standard dose (0.1 mmol/kg) were similar to adults and children 2 years of age and older Diagnostic use in approved indications has been expanded to include use in pediatric patients less than 2 years of age, including term newborns New expanded use...Read more